Back

Troponin antibodies and macrotroponin: a common cause of troponin I elevation in elite endurance athletes

23 April 2026 (14:00 - 14:15)
Organised by: Logo
Congress Presentation Part of: Young Investigator Award - Sports Cardiology and Exercise Athlete´s Heart EAPC Premium Access ESC Preventive Cardiology 2026 European Association of Preventive Cardiology (EAPC)

About the speaker

Photo
Doctor Stephanie Rowe

St. Vincent's Institute of Medical Research, Melbourne (Australia)

3 More presentations in this session

Presentation thumbnail
Targeting mitochondrial dysfunction with the exercise-derived metabolite beta-aminoisobutyric acid protects against doxorubicin-induced cardiomyopathy
Mr R. Numazawa (Sapporo, JP)
Abstract Slides Video
Presentation thumbnail
Outcomes of a nationwide cardiac screening programme in young females
Doctor D. Tardo (London, GB)
Abstract Slides Video
Presentation thumbnail
Feasibility of a novel points-based health questionnaire utilised in a nationwide cardiac screening programme for young individuals
Doctor H. MacLachlan (London, GB)
Abstract Slides Video

Access the full session

Session thumbnail
Young Investigator Award - Sports Cardiology and Exercise
Video

The Event

Event poster

ESC Preventive Cardiology 2026

23 April 2026 14:00 CET
You may be interested in
thumbnail
Congress Presentation
Prevalence of cardiac troponin elevations in athletes following running, cycling, or walking events
thumbnail
Congress Presentation
False-positive cardiac troponin I values in healthy athletes post COVID-19 Infection: concerning insights from a prospective cohort study
thumbnail
Congress Presentation
Exercise-induced cardiac troponin I in an individual with progressive coronary artery disease

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources